Regulated bioanalysis continues to evolve alongside increasingly complex therapeutic modalities and the need to accelerate drug development without compromising data quality. Recent years have seen a shift toward more streamlined, fit-for-purpose bioanalytical strategies, prompting a re-evaluation of long-standing conventions while remaining firmly grounded in science. 

This seminar will highlight current hot topics in pharmacokinetic (PK), immunogenicity (ADA/NAb), and biomarker bioanalysis, with a focus on the practical application of scientific and regulatory principles in drug development programs. Presentations will explore how context-of-use, risk-based decision-making, and thoughtful assay design can be applied in practice, with case studies providing practical examples of bioanalytical approaches that support efficient and accelerated drug development. 

Event sponsored by...

Attendance: This event is free to attend and invite only. To request an invite, please contact [email protected] at your earliest convenience.